| Literature DB >> 31035943 |
Charlotte Tchente Nguefack1, Cecile Okalla Ebongue2, Chrystelle Nouwe Chokotheu3, Cedric Ebong Ewougo4, Théophile Nana Njamen5, Emile Mboudou6.
Abstract
BACKGROUND: Pregnancy increases the risk of recurrent bacteriuria and acute pyelonephritis which is associated with significant maternal and fetal risks. The prevalence of bacteriuria varies worldwide. Clinical diagnosis is challenging since it is usually mistaken for normal physiological changes during pregnancy. This study aims to determine the prevalence, clinical presentation, risk factors and microorganism responsible for bacteriuria in pregnant women of Douala city, Cameroun.Entities:
Keywords: Bacteriuria; Clinical presentation; Pathogens; Pregnancy; Risk factors
Year: 2019 PMID: 31035943 PMCID: PMC6489255 DOI: 10.1186/s12884-019-2290-y
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Pathogens identified in pregnant women with bacteriuria
| Germs | Number | Percentage |
|---|---|---|
|
| 17 | 48.6 |
|
| 5 | 14.3 |
|
| 4 | 11.4 |
|
| 3 | 8.6 |
|
| 2 | 5.7 |
|
| 1 | 2.9 |
|
| 1 | 2.9 |
|
| 1 | 2.9 |
|
| 1 | 2.9 |
| Total | 35 | 100 |
Association between socio-demographic factors and bacteriuria in pregnancy
| characteristics | bacteriuria | OR (IC à 95%) | p | ||
|---|---|---|---|---|---|
| positive | negative | total | |||
| Age | |||||
| 18–22 | 5(11.1) | 40(88. 9) | 45(12.7) | 1 | |
| 23–27 | 12(10.2) | 106(89.8) | 118(33.3) | 0.906 (0.3–2.734) | 0.86 |
| 28–32 | 13(10.8) | 107(89.2) | 120(33.9) | 0.972 (0.326–2.901) | 0.95 |
| 33–37 | 3(5.4) | 53(94.6) | 56(15.8) | 0.453 (0.102–2.008) | 0.29 |
| 38–42 | 2(13.3) | 13(86.7) | 15(4.2) | 1.231 (0.213–7.12) | 0.81 |
| Marital status | |||||
| Single | 17(13.8) | 106(86.2) | 123(65.3) | ||
| Married | 18(7.8) | 213(92.2) | 231(34.7) | 0.537 (0.252–1.145) | 0.11 |
| Education | |||||
| illiterate | 2(50) | 2(50) | 4(1.1) | 1 | |
| Primary | 3(7.9) | 35(92.1) | 38(10.7) | 0.088 (0.009–0.872) |
|
| Secondary | 14(10.1) | 124(89.9) | 138(39) | 0.113 (0.015–0.874) |
|
| University | 16(9.2) | 158(90.8) | 174(49.2) | 0.106 (0.014–0.81) |
|
| Income /Month | |||||
| No income | 17(8.6) | 180(91.4) | 197(55.6) | 1 | |
| ≤ 35,000 | 5(10.6) | 42(89.4) | 47(13.3) | 1.237 (0.409–3.74) | 0.70 |
| > 35,000 | 13(11.8) | 97(88.2) | 110(31.1) | 0.738 (0.255–2.135) | 0.57 |
The significance of entries in boldface: significant p value
Association between obstetrical factors and urinary tract infection
| Characteristics | Bacteriuria Positive | Negative | Total | OR (CI: 95%) | P |
|---|---|---|---|---|---|
| Gestational age | |||||
| 1st Trimester | 5(6.9) | 67(93.1) | 72(20.3) | 1 | |
| 2nd Trimester | 16(11.9) | 118(88.1) | 134(37.9) | 0.82 (0.43–1.57) | 0.55 |
| 3rd Trimester | 14(9.5) | 143(90.5) | 148(41.8) | 0.75 (0.40–1.42) | 0.37 |
| Parity | |||||
| Parity 0 | 17(11.9) | 126(88.1) | 143(40.4) | 1 | |
| Parity 1 | 8(9.2) | 79(90.8) | 87(24.6) | 0.797 (0.317–2.003) | 0.62 |
| Parity 2 | 5(7.6) | 61(92.4) | 66(18.6) | 0.65 (0.22–1.919) | 0.43 |
| Parity 3 | 2(5.4) | 35(94.6) | 37(10.5) | 0.486 (0.096–2.454) | 0.38 |
| Parity 4 | 2(13.3) | 13(86.7) | 15(4.2) | 1.362 (0.238–7.783) | 0.72 |
| Parity 5 | 1(20) | 4(80) | 5(1.4) | 2.207 (0.206–23.605) | 0.51 |
| Parity 6 | 0(0.0) | 1(100) | 1(0.3) | 0.023 (0.001–129.25) | 0.99 |
Association between medical and obstetrical past history and urinary tract infection
| Characteristics | Bacteriuria | OR (IC:95%) | P | ||
|---|---|---|---|---|---|
| Positive | Negative | Total | |||
| Sexuality | |||||
| < 3times/week | 32(10) | 287(90) | 319(90.1) | ||
| ≥ 3times/week | 3(8.6) | 32(91.4) | 35(9.9) | 0.834 (0.241–2.882) | 0.77 |
| Past history of UTI | |||||
| No | 21(8) | 243(92) | 264(74.6) | ||
| Yes | 14(15.6) | 76(84.4) | 90(25.4) | 2.183 (1.055–4.518) |
|
| Past history of miscarriage | |||||
| No | 28(10.6) | 236(89.4) | 264(74.6) | ||
| Yes | 7(7.8) | 83(92.2) | 90(25.4) | 1.09 (0.63–1.88) | 0.75 |
| Past history of Premature labor | |||||
| No | 34(9.9) | 307(90.1) | 341(96.3) | ||
| Yes | 1(7.7) | 12(92.3) | 13(3.7) | 0.81 (0.101–6.491) | 0.84 |
| HIVa | |||||
| No | 34(10.1) | 301(89.9) | 335(94.6) | ||
| Yes | 1(5.3) | 18(94.7) | 19(5.4) | 0.517 (0.067–4.021) | 0.52 |
| BMIb | |||||
| Normal | 13(11.7) | 98(88.3) | 111(31.4) | 1 | |
| Overweigh | 11(8.6) | 117(91.4) | 128(36.2) | 0.709 (0.304–1.653) | 0.42 |
| Stage 1obesity | 6(7.1) | 78(92.9) | 84(23.7) | 0.58 (0.211–1.596) | 0.29 |
| Stage 2 obesity | 5(18.5) | 22(81.5) | 27(7.6) | 1.713 (0.553–5.306) | 0.35 |
| Stage 3 obesity | 0(0) | 4(100) | 4(1.1) | 0.03 (0.006–0.1) | 0.97 |
a: Human Immunodeficiency Virus; b: Body Mass Index
The significance of entries in boldface: significant p value